Agios Pharmaceuticals, Inc. (AGIO)
26.81
-0.47
(-1.72%)
USD |
NASDAQ |
Dec 09, 16:00
26.85
+0.04
(+0.15%)
After-Hours: 17:23
Agios Pharmaceuticals Shareholders Equity (Quarterly): 1.284B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Fulcrum Therapeutics, Inc. | 198.37M |
| Moderna, Inc. | 9.33B |
| EyePoint Pharmaceuticals, Inc. | 200.18M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.386B |
| Total Liabilities (Quarterly) | 101.38M |
| Debt to Equity Ratio | 0.0347 |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.17% |